WALTHAM, Mass., March 16, 2026 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced that on March 16, 2026 (the “Grant Date”), the Compensation Committee of […]
Category Archives: Pr Newswire
Pr Newswire
Imprivata Introduces New Advanced Access Management and Passwordless Authentication Capabilities to Enhance Clinical Efficiency, Security, and Essential Eight Compliance
17
Mar
Mar
Imprivata Enterprise Access Management now offers facial recognition, AI-powered behavioral analytics, and high-assurance identity verification to further streamline clinical access, improve operational efficiency, and strengthen security posture MELBOURNE, March 16, 2026 (GLOBE NEWSWIRE) — Imprivata, a leading provider of access management solutions for healthcare and other mission-critical industries, today introduced comprehensive new capabilities designed to […]
17
Mar
Mar
Cambridge-based surgical robotics company contributes majority of surgical data to world’s largest open healthcare robotics dataset Cambridge, UK and San Jose, California – 16 March 2026, CMR Surgical (“CMR”), the global surgical robotics company, today announced its participation in NVIDIA’s Physical AI healthcare robotics initiative, unveiled at NVIDIA GTC. As part of the initiative, CMR […]
Pr Newswire
Roche launches NVIDIA AI factory to accelerate the development of new therapeutics and diagnostics solutions
17
Mar
Mar
With the addition of 2,176 NVIDIA Blackwell GPUs, Roche now operates the pharmaceutical industry’s largest announced hybrid-cloud AI factory, totaling more than 3,500 GPUs. The new computational infrastructure supports Roche’s vision of building an AI-accelerated healthcare organisation. NVIDIA AI factories help accelerate discoveries, enable more efficient clinical trials, and unlock data insights at scale, ultimately […]
Facing escalating licensing fees for its Enterprise Linux stack, the company chose CIQ to manage migration to and stable, long-term support for Rocky Linux from CIQ. SEOUL, South Korea, March 17, 2026 CIQ, the founding support and services partner of Rocky Linux and a leader in high-performance software infrastructure, has been selected by LG Uplus […]
SINGAPORE, March 17, 2026 /PRNewswire/ — Lester Chan, CEO & Chairman, The GrowHub Limited (Nasdaq: TGHL) explains how forests, mangroves, and peatlands are reshaping climate strategy The first wave of carbon markets was about avoidance. The second wave is about removal. The third—gathering momentum now—is about nature itself. Across Asia, governments are recognising a fundamental […]
Largest Fund Raised to Date by Starlight, Enabling the Acquisition of over 10,000 Rental Suites TORONTO, March 17, 2026 /PRNewswire/ — Starlight Investments (“Starlight”), a leading global real estate investment and asset management firm, today announced the successful closing of Starlight Canadian Residential Growth Fund IV (“Growth Fund IV”), the fourth fund in the firm’s […]
New platform unifies collections, currency conversion, funding and settlement, enabling same-day global payments SYDNEY, March 17, 2026 /PRNewswire/ — Today, Monoova announced the launch of its FX Hub, a new capability bringing domestic collections, foreign exchange conversion, funding, and settlement into a single automated flow. Global payments are often slowed by fragmented banking relationships, multiple […]
DALLAS, March 17, 2026 /PRNewswire/ — Cango Inc. (NYSE: CANG), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025. Financial and Operational Highlights Total revenues were $688.1 million for the full year, […]
Pr Newswire
Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session
16
Mar
Mar
MONTREAL and CHARLOTTE, N.C., March 16, 2026 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that a moderated poster presentation titled “Minimal Blood Pressure Effects of Intranasal Etripamil in Trials for Paroxysmal Supraventricular Tachycardia (PSVT)” will be featured at the […]